Relationship between Preoperative 18F-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Status in Primary Colorectal Cancer

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Primary Colorectal Cancer ◽

Receptor Status ◽

18F Fluorodeoxyglucose ◽

Correction: Lack of Correlation between Epidermal Growth Factor Receptor Status and Response to Panitumumab Monotherapy in Metastatic Colorectal Cancer: Fig. 2.

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-10-0766 ◽

2010 ◽

Vol 16 (10) ◽

pp. 2917-2917

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Receptor Status ◽

Epidermal growth factor receptor (EGFR) mRNA levels and protein expression levels in primary colorectal cancer and corresponding liver metastases

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-009-1087-5 ◽

2009 ◽

Vol 65 (5) ◽

pp. 825-831 ◽

Cited By ~ 8

Author(s):

Hidekazu Kuramochi ◽

Kazuhiko Hayashi ◽

Go Nakajima ◽

Hirotaka Kamikozuru ◽

Masakazu Yamamoto ◽

...

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Protein Expression ◽

Liver Metastases ◽

Growth Factor Receptor ◽

Mrna Levels ◽

Primary Colorectal Cancer ◽

The relationship between epidermal growth factor receptor (EGFR) mRNA levels and protein expression in primary colorectal cancer and corresponding liver metastases

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.15021 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 15021-15021

Author(s):

H. Kuramochi ◽

K. Hayashi ◽

G. Nakajima ◽

K. D. Danenberg ◽

P. V. Danenberg ◽

...

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Liver Metastases ◽

Growth Factor Receptor ◽

Mrna Levels ◽

Primary Colorectal Cancer ◽

Epidermal Growth ◽

The Relationship

Lack of Correlation between Epidermal Growth Factor Receptor Status and Response to Panitumumab Monotherapy in Metastatic Colorectal Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-09-2017 ◽

2010 ◽

Vol 16 (7) ◽

pp. 2205-2213 ◽

Cited By ~ 66

Author(s):

J. Randolph Hecht ◽

Edith Mitchell ◽

Marcus A. Neubauer ◽

Howard A. Burris ◽

Paul Swanson ◽

...

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Receptor Status ◽

Does epidermal growth factor receptor status predict activity of cetuximab in colorectal cancer patients?

Nature Clinical Practice Oncology ◽

10.1038/ncponc0165 ◽

2005 ◽

Vol 2 (6) ◽

pp. 284-285 ◽

Cited By ~ 8

Author(s):

José Baselga

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Patients ◽

Growth Factor Receptor ◽

Receptor Status ◽

Epidermal Growth ◽

Colorectal Cancer Patients

Anti-Epidermal Growth Factor Receptor Antibodies in the Treatment of Metastatic Colorectal Cancer

Recent Patents on Anti-Cancer Drug Discovery ◽

10.2174/1574209199544168928 ◽

2009 ◽

Vol 999 (999) ◽

pp. 1-8

Author(s):

Anne Kendall ◽

Rosemary Lord ◽

Nick Maisey

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Receptor Antibodies

The inhibitory effect of ECG and EGCG dimeric procyanidins on colorectal cancer cells growth is associated with their actions at lipid rafts and the inhibition of the epidermal growth factor receptor signaling

Biochemical Pharmacology ◽

10.1016/j.bcp.2020.113923 ◽

2020 ◽

Vol 175 ◽

pp. 113923 ◽

Cited By ~ 1

Author(s):

Wei Zhu ◽

Mei C. Li ◽

Feng R. Wang ◽

Gerardo G. Mackenzie ◽

Patricia I. Oteiza

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Cells ◽

Growth Factor Receptor ◽

Inhibitory Effect ◽

Colorectal Cancer Cells ◽

Epidermal Growth ◽

Growth Factor Receptor Signaling

To Give or Not to Give Anti–Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies to Patients With KRAS G13D Mutation in Advanced Colorectal Cancer

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2011.10.005 ◽

2012 ◽

Vol 11 (2) ◽

pp. 85-87 ◽

Cited By ~ 1

Author(s):

Richard Kim ◽

Timothy Kubal

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibodies ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Advanced Colorectal Cancer ◽

Growth Factor Receptor ◽

Impact of tumor epidermal growth factor receptor (EGFR) status on the outcomes of first-line FOLFOX-4 ± cetuximab in patients (pts) with RAS-wild-type (wt) metastatic colorectal cancer (mCRC) in the randomized phase 3 TAILOR trial

Annals of Oncology ◽

10.1093/annonc/mdw370.75 ◽

2016 ◽

Vol 27 ◽

pp. vi174 ◽

Cited By ~ 2

Author(s):

S. Qin ◽

J. Xu ◽

L. Wang ◽

Y. Cheng ◽

T. Liu ◽

...

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Wild Type ◽

First Line ◽

Phase 3 ◽

PTEN Gene Expression and Mutations in the PIK3CA Gene as Predictors of Clinical Benefit to Anti-Epidermal Growth Factor Receptor Antibody Therapy in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2011.12.001 ◽

2012 ◽

Vol 11 (2) ◽

pp. 143-150 ◽

Cited By ~ 61

Author(s):

Arjun Sood ◽

Danielle McClain ◽

Radhashree Maitra ◽

Atrayee Basu-Mallick ◽

Raviraja Seetharam ◽

...

Keyword(s):

Gene Expression ◽

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Antibody Therapy ◽

Growth Factor Receptor ◽

Pten Gene ◽

Wild Type ◽